Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-blind, Placebo-controlled, Crossover, Multi-center Clinical Trial for the Evaluation of Efficacy, Safety, and Tolerability of ASY202 for the Acute Treatment of Migraine in Adult Patients

NCT07646613 is registered in ClinicalTrials.gov with Aspeya, Inc. as lead sponsor.

NCT NCT07646613
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07646613 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-blind, Placebo-controlled, Crossover, Multi-center Clinical Trial for the Evaluation of Efficacy, Safety, and Tolerability of ASY202 for the Acute Treatment of Migraine in Adult Patients
Lead sponsor
Aspeya, Inc.
Phase
Phase 2
Overall status
Recruiting
Start date
May 19, 2026
Completion date
March 31, 2027
Enrollment
108 (estimated)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

migraine